Ignite Creation Date:
2025-12-24 @ 5:37 PM
Ignite Modification Date:
2026-03-18 @ 6:48 AM
Study NCT ID:
NCT05438368
Status:
RECRUITING
Last Update Posted:
2022-06-30
First Post:
2022-06-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
GD2/CD70 Bi-specific CAR-T Cell Therapy
Sponsor:
Shenzhen Geno-Immune Medical Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GIMI-IRB-22005
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None